Key regions: United Kingdom, Canada, Japan, Europe, China
The demand for dermatological drugs in Chad has been on the rise in recent years, driven by various factors.
Customer preferences: Chadian consumers are increasingly becoming aware of the importance of skincare and are willing to invest in dermatological drugs to treat various skin conditions. This trend is particularly evident among the younger population, who are more conscious of their appearance and seek to maintain healthy skin.
Trends in the market: The dermatological drugs market in Chad is witnessing a shift towards more natural and organic products. Consumers are increasingly seeking products that are free from harmful chemicals and are made from natural ingredients. This trend is in line with the global trend towards clean beauty and is expected to continue in the coming years.
Local special circumstances: Chad is a landlocked country with limited access to the sea, which makes it difficult to import products from other countries. This has led to the development of a local manufacturing industry for dermatological drugs, with several local companies producing a range of skincare products.
Underlying macroeconomic factors: Chad is one of the poorest countries in the world, with a large proportion of the population living below the poverty line. This has limited the growth of the dermatological drugs market, as many consumers cannot afford to purchase expensive skincare products. However, the increasing awareness of the importance of skincare and the availability of affordable local products are expected to drive the growth of the market in the coming years.In conclusion, the dermatological drugs market in Chad is witnessing a shift towards more natural and organic products, driven by increasing consumer awareness of the importance of skincare. The local manufacturing industry is also playing a significant role in the growth of the market, providing affordable products to consumers. However, the market is limited by the country's economic situation, with many consumers unable to afford expensive skincare products.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
